Cardinal Health Inc vs Koninklijke Philips NV — how do they compare? Cardinal Health Inc trades at $240.39 (market cap $55.55B), while Koninklijke Philips NV trades at $26.99 (market cap $26.33B). The key difference: Cardinal Health Inc is far larger — about 2.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| CAH | PHG | |
|---|---|---|
Market Cap | $55.55B | $26.33B |
Sector | Health | Health |
52-Week High | $240.26 | $32.91 |
52-Week Low | $146.04 | $25.02 |
Enterprise Value | $60.53B | $32.89B |
Dividend Yield | 0.86% | 3.76% |
Trailing returns across standard periods
Latest headlines on both assets
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →